BioSpace News Archive

By any measure, the Wind River Experimental Forest is a remote area. Yet two teams of ecologists managed to meet up and collaborate in their efforts to study the federally threatened Steelhead Trout species (Oncorhynchus mykiss) and map the long-term overall health of the aquatic system.

CMI Time Management, a leading global provider of innovative workforce and resource management products for companies in a variety of major industries, announced the release of the latest entry in its proprietary TouchTime line of data collection terminals.

VGXI, an industry recognized plasmid DNA contract manufacturing organization, announced the grand opening of a facility expansion which includes flexible scale plasmid DNA manufacturing space as well as purpose-built GMP production areas for RNA synthesis.

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced positive longer-term results from the open-label, dose-escalating Phase 1b trial of VY-AADC demonstrating sustained improvements in patients’ motor function.

Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced that it has expanded its direct sales of Cytocell Fluorescence In Situ Hybridisation (FISH) products to include the Asia-Pacific (APAC) region.

ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe, today reported financial results for the quarter ended 30 September 2018 and provided an update on its clinical activities.

Altasciences is excited to announce the completion of their laboratory expansion.

Transaction Expected to Position Bioceres to Execute on Compelling Growth Opportunities in the Global Agricultural Biotechnology Markets

IDBS, a leader in enterprise scientific informatics platforms, today announced the appointments of Graeme Dennis as Pre-Clinical Pharma Commercial Director, Abhay Kini as Director of Product Management and April Pisek as Solutions Consultant.